Efficacy and Safety of Plasma Exchange with Albumin Replacement as a Therapy for Amyotrophic Lateral Sclerosis
Background: Neuroinflammation is being increasingly recognized as a key factor in the pathogenesis of amyotrophic lateral sclerosis (ALS). A therapeutic approach for ALS using plasma exchange with albumin replacement (PE-A) has been proposed to remove antibody complexes, inflammatory mediators, and...
Main Authors: | Dennis Okumu Obat, Mirjana Stevanovic, Catherine Andrews, Elsa Mondou, Zbigniew Szczepiorkowski, Miquel Barceló, Michael Ken Woodward, Nuria Ribó, Wei Liang, Elijah Stommel |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2022-08-01
|
Series: | Plasmatology |
Online Access: | https://doi.org/10.1177/26348535221114460 |
Similar Items
-
The Cyanobacteria Derived Toxin Beta-N-Methylamino-L-Alanine and Amyotrophic Lateral Sclerosis
by: Elijah W. Stommel, et al.
Published: (2010-12-01) -
Elevated Cerebrospinal Fluid Proteins and Albumin Determine a Poor Prognosis for Spinal Amyotrophic Lateral Sclerosis
by: Abdelilah Assialioui, et al.
Published: (2022-09-01) -
Amyotrophic lateral sclerosis.
by: Kiernan, M, et al.
Published: (2011) -
Nationwide survey of medical student interest in and exposure to aerospace medicine
by: Semran B. Thamer, et al.
Published: (2023-06-01) -
A new method for estimating under-recruitment of a patient registry: a case study with the Ohio Registry of Amyotrophic Lateral Sclerosis
by: Meifang Li, et al.
Published: (2022-08-01)